Effects of TrkB agonist 7,8-dihydroxyflavone on sensory gating deficits in mice after administration of methamphetamine

Pharmacology Biochemistry and Behavior

Volumn 106, Issue , 2013, Pages 124-127

  Ren, Qian ^a   Zhang, Ji Chun ^a   Fujita, Yuko ^a   Ma, Min ^a   Wu, Jin ^a   Hashimoto, Kenji ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

7,8 Dihydroxyflavone; Dopamine; Methamphetamine; Prepulse inhibition; Schizophrenia; TrkB agonist

Indexed keywords

7,8 DIHYDROXYFLAVONE; ANA 12; DOPAMINE; METHAMPHETAMINE; RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; DOSE RESPONSE; DRUG EFFECT; MALE; MICRODIALYSIS; MOUSE; NONHUMAN; PREPULSE INHIBITION; PRIORITY JOURNAL; SENSORY GATING;

ANIMALS; FLAVONES; ION CHANNEL GATING; MALE; METHAMPHETAMINE; MICE; MICRODIALYSIS; RECEPTOR, TRKB;

MUS;

EID: 84878261788     PISSN: 00913057     EISSN: 18735177     Source Type: Journal    
DOI: 10.1016/j.pbb.2013.03.016     Document Type: Article

References (46)

1. R. Andero, S.A. Heldt, K. Ye, X. Liu, A. Armario, and K.J. Ressler Effect of 7,8-dihydroxyflavone, a small-molecule TrkB agonist, in emotional learning Am J Psychiatry 168 2011 163 172
2. S. Arai, K. Takuma, H. Mizoguchi, D. Ibi, T. Nagai, and K. Takahashi Involvement of pallidotegmental neurons in methamphetamine- and MK-801-induced impairment of prepulse inhibition of the acoustic startle reflex in mice: reversal by GABAB receptor agonist baclofen Neuropsychopharmacology 33 2008 3164 3175
3. A. Blugeot, C. Rivat, E. Bouvier, J. Molet, A. Mouchard, and B. Zeau Vulnerability to depression: from brain neuroplasticity to identification of biomarkers J Neurosci 31 2011 12889 12899
4. D.L. Braff, and M.A. Geyer Sensorimotor gating and schizophrenia. Human and animal model studies Arch Gen Psychiatry 47 1990 181 188 (Pubitemid 20058094)
5. H. Chen, J. Wu, J. Zhang, and K. Hashimoto Recent topics on pharmacotherapy for amphetamine-type stimulants abuse and dependence Curr Drug Abuse Rev 3 2010 222 238
6. J. Chen, K.W. Chua, C.C. Chua, H. Yu, A. Pei, and B.H. Chua Antioxidant activity of 7,8-dihydroxyflavone provides neuroprotection against glutamate-induced toxicity Neurosci Lett 499 2011 181 185
7. H. Chen, J. Wu, J. Zhang, Y. Fujita, T. Ishima, and M. Iyo Protective effects of the antioxidant sulforaphane on behavioral changes and neurotoxicity in mice after the administration of methamphetamine Psychopharmacology (Berl) 222 2012 37 45
8. P.H. Chen, M.C. Huang, Y.C. Lai, P.Y. Chen, and H.C. Liu Serum brain-derived neurotrophic factor levels were reduced during methamphetamine early withdrawal Addict Biol 2013 10.1111/j.1369-1600.2012.00444.x [in press]
9. H. Dai, H. Okuda, K. Iwabuchi, E. Sakurai, Z. Chen, and M. Kato Social isolation stress significantly enhanced the disruption of prepulse inhibition in mice repeatedly treated with methamphetamine Ann N Y Acad Sci 1025 2004 257 266 (Pubitemid 39643870)
10. A.C. Dean, S.M. Groman, A.M. Morales, and E.D. London An evaluation of the evidence that methamphetamine abuse causes cognitive decline in humans Neuropsychopharmacology 38 2013 259 274
11. L. Devi, and M. Ohno 7,8-dihydroxyflavone, a small-molecule TrkB agonist, reverses memory deficits and BACE1 elevation in a mouse model of Alzheimer's disease Neuropsychopharmacology 37 2012 434 444
12. K.B.L. Frankin, and G. Paxinos The mouse brain in stereotaxic coordinates 1997 CA. Academic Press San Diego
13. Y. Fujita, S. Kunitachi, M. Iyo, and K. Hashimoto The antibiotic minocycline prevents methamphetamine-induced rewarding effects in mice Pharmacol Biochem Behav 101 2012 303 306
14. M. Gazorla, J. Premont, A. Mann, N. Girard, C. Kellendorink, and D. Rognan Identification of a low-molecular weight TrkB antagonist with anxiolytic and antidepressant activity in mice J Clin Invest 121 2011 1846 1857
15. M.A. Geyer, K. Krebs-Thomson, D.L. Braff, and N.R. Swerdlow Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review Psychopharmacology (Berl) 156 2001 117 154 (Pubitemid 32702206)
16. R. Gonzales, L. Mooney, and R.A. Rawson The methamphetamine problem in the United States Annu Rev Public Health 31 2010 385 398
17. K. Hashimoto New research on methamphetamine abuse Chapter 1 G.H. Toolaney, New research on methamphetamine abuse 2007 Nova Science Publishers, Inc. New York 1 51
18. K. Hashimoto Sigma-1 receptor chaperone and brain-derived neurotrophic factor: emerging links between cardiovascular disease and depression Prog Neurobiol 100 2013 15 29
19. K. Hashimoto, Y. Fujita, M. Horio, S. Kunitachi, M. Iyo, and D. Ferraris Co-administration of a d-amino acid oxidase inhibitor potentiates the efficacy of d-serine in attenuating prepulse inhibition deficits after administration of dizocilpine Biol Psychiatry 65 2009 1103 1106
20. K. Hashimoto, Y. Fujita, M. Horio, H. Hagiwara, Y. Tanibuchi, and M. Iyo Effects of cilostazol on dizocilpine-induced hyperlocomotion and prepulse inhibition deficits in mice Clin Psychopharmacol Neurosci 8 2010 74 78
21. M. Horio, Y. Fujita, T. Ishima, M. Iyo, D. Ferraris, and T. Tsukamoto Effects of d-amino acid oxidase inhibitor on the extracellular d-alanine levels and the efficacy of d-alanine on dizocilpine-induced prepulse inhibition deficits in mice Open Clin Chem J 2 2009 16 21
22. S.W. Jang, X. Liu, M. Yepes, K.R. Shepherd, G.W. Miller, and Y. Liu A selective TrkB agonist with potent neurotrophic activities by 7,8-dihydroxyflavone Proc Natl Acad Sci U S A 107 2010 2687 2692
23. D.C. Javitt, and S.R. Zukin Recent advances in the phencyclidine model of schizophrenia Am J Psychiatry 148 1991 1301 1308
24. L. Karila, A. Weinstein, H.J. Aubin, A. Benyamina, M. Reynaud, and S.L. Batki Pharmacological approaches to methamphetamine dependence: a focused review Br J Clin Pharmacol 69 2010 578 592
25. J.H. Krystal, E.B. Perry Jr., R. Gueorguieva, A. Belger, S.H. Madonick, and A. Abi-Dargham Comparative and interactive human psychopharmacologic effects of ketamine and amphetamine: implications for glutamatergic and dopaminergic model psychoses and cognitive function Arch Gen Psychiatry 62 2005 985 994
26. X. Liu, C.B. Chan, S.W. Jang, S. Pradoldej, J. Huang, and K. He A synthetic 7,8-dihydroxyflavone derivative promotes neurogenesis and exhibits potent antidepressant effect J Med Chem 53 2010 8274 8286
27. X. Liu, C.B. Chan, Q. Qi, G. Xiao, H.R. Luo, and X. He Optimization of a small tropomyosin-related kinase B (TrkB) agonist 7,8-dihydroxyflavone active in mouse models of depression J Med Chem 55 2012 8524 8537
28. J.F. McGinty, A.J. Bache, N.T. Coleman, and W.L. Sun The role of BDNF/TrkB signaling in acute amphetamine-induced locomotor activity and opioid peptide gene expression in the rat dorsal striatum Front Syst Neurosci 5 2011 60
29. H. Mizoguchi, S. Arai, H. Koike, D. Ibi, H. Kamei, and T. Nabeshima Therapeutic potential of nicotine for methamphetamine-induced impairment of sensorimotor gating: involvement of pallidotegmental neurons Psychopharmacology (Berl) 207 2009 235 243
30. J. Moncrieff A critique of the dopamine hypothesis of schizophrenia and psychosis Harv Rev Psychiatry 17 2009 214 225
31. M. Narita, K. Aoki, M. Takagi, Y. Yajima, and T. Suzuki Implication of brain-derived neurotrophic factor in the release of dopamine and dopamine-related behaviors induced by methamphetamine Neuroscience 119 2003 767 775 (Pubitemid 36694803)
32. H.Y. Park, G.Y. Kim, J.W. Hyun, H.J. Hwang, N.D. Kim, and B.W. Kim 7,8-Dihydroxyflavone exhibits anti-inflammatory properties by downregulating the NF-κB and MAPK signaling pathways in lipopolysaccharide-treated RAW264.7 cells Int J Mol Med 29 2012 1146 1152
33. W. Perry, M.A. Geyer, and D.L. Braff Sensorimotor gating and thought disturbance measured in close temporal proximity in schizophrenic patients Arch Gen Psychiatry 56 1999 277 281 (Pubitemid 29125137)
34. R.J. Ralph-Williams, V. Lehmann-Masten, V. Otero-Corchon, M.J. Low, and M.A. Geyer Differential effects of direct and indirect dopamine agonists on prepulse inhibition: a study in D1 and D2 receptor knock-out mice J Neurosci 22 2002 9604 9611 (Pubitemid 35356202)
35. T.E. Robinson, and J.B. Becker Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis Brain Res 396 1986 157 198 (Pubitemid 16100809)
36. M. Sato, Y. Numachi, and T. Hamamura Relapse of paranoid psychotic state in methamphetamine model of schizophrenia Schizophr Bull 18 1992 115 122
37. Y. Sekine, Y. Ouchi, G. Sugihara, N. Takei, E. Yoshikawa, and K. Nakamura Methamphetamine causes microglial activation in the brains of human abusers J Neurosci 28 2008 5756 5761
38. Y. Shirai, Y. Fujita, and K. Hashimoto Effects of the antioxidant sulforaphane on hyperlocomotion and prepulse inhibition deficits in mice after administration of phencyclidine Clin Psychopharmacol Neurosci 10 2012 94 98
39. S.H. Snyder Amphetamine psychosis: a "model" of schizophrenia mediated by catecholamines Am J Psychiatry 130 1973 61 67
40. S.H. Snyder The dopamine hypothesis of schizophrenia: focus on the dopamine receptor Am J Psychiatry 133 1976 197 202
41. N.R. Swerdlow, D.L. Braff, N. Taaid, and M.A. Geyer Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients Arch Gen Psychiatry 51 1994 139 154 (Pubitemid 24985903)
42. Y. Tanibuchi, Y. Fujita, M. Kohno, T. Ishima, Y. Takatsu, and M. Iyo Effects of quetiapine on phencyclidine-induced cognitive deficits in mice: a possible role of α1-adrenoceptors Eur Neuropsychopharmacol 19 2009 861 867
43. Y. Zeng, F. Lv, L. Li, H. Yu, M. Dong, and Q. Fu 7,8-Dihydroxyflavone rescues spatial memory and synaptic plasticity in cognitively impaired aged rats J Neurochem 122 2012 800 811
44. Y. Zeng, Y. Liu, M. Wu, J. Liu, and Q. Hu Activation of TrkB by 7,8-dihydroxyflavone prevents fear memory defects and facilitates amygdalar synaptic plasticity in aging J Alzheimers Dis 31 2012 765 778
45. L. Zhang, K. Kitaichi, Y. Fujimoto, H. Nakayama, E. Shimizu, and M. Iyo Protective effects of minocycline on behavioral changes and neurotoxicity in mice after administration of methamphetamine Prog Neuropsychopharmacol Biol Psychiatry 30 2006 1381 1393 (Pubitemid 44634942)
46. L. Zhang, Y. Shirayama, M. Iyo, and K. Hashimoto Minocycline attenuates hyperlocomotion and prepulse inhibition deficits in mice after administration of the NMDA receptor antagonist dizocilpine Neuropsychopharmacology 32 2007 2004 2010 (Pubitemid 47258509)